S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
NASDAQ:ENOB

Enochian Biosciences News Headlines

$5.53
-0.19 (-3.32%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.46
$5.75
50-Day Range
$5.53
$12.55
52-Week Range
$2.86
$13.78
Volume
220,237 shs
Average Volume
198,076 shs
Market Capitalization
$288.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.41
Get Enochian Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Enochian Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENOB
News Sentiment

-0.01

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENOB Articles
This Week

2

0

ENOB Articles
Average Week



Enochian Biosciences (NASDAQ:ENOB) News Headlines Today

SourceHeadline
MarketBeat logoEnochian Biosciences, Inc. (NASDAQ:ENOB) Short Interest Update
americanbankingnews.com - January 17 at 12:38 PM
finance.yahoo.com logoEnochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors
finance.yahoo.com - December 3 at 10:11 AM
finance.yahoo.com logoEnochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month
finance.yahoo.com - October 18 at 7:57 AM
finance.yahoo.com logoEnochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month
finance.yahoo.com - October 18 at 7:57 AM
finanznachrichten.de logoEnochian BioSciences, Inc.: Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
finanznachrichten.de - October 15 at 7:48 PM
finance.yahoo.com logoScientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
finance.yahoo.com - October 15 at 7:48 PM
finance.yahoo.com logoScientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
finance.yahoo.com - October 15 at 7:48 PM
nz.finance.yahoo.com logoFireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference
nz.finance.yahoo.com - October 12 at 7:46 PM
finance.yahoo.com logoFireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference
finance.yahoo.com - October 12 at 6:10 PM
benzinga.com logoEnochian BioSciences Announces Its Completion Of FDA Pre-IND Process For ENOB-HB-01
benzinga.com - September 27 at 9:52 AM
finance.yahoo.com logoEnochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection
finance.yahoo.com - September 27 at 7:22 AM
finance.yahoo.com logoIs Enochian Biosciences (NASDAQ:ENOB) Using Debt In A Risky Way?
finance.yahoo.com - September 26 at 11:17 AM
finance.yahoo.com logoEnochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference
finance.yahoo.com - September 13 at 7:35 AM
nasdaq.com logoEnochian Biosciences (NASDAQ:ENOB) Is Making Moderate Use Of Debt
nasdaq.com - September 2 at 8:34 AM
finance.yahoo.com logoDistinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants
finance.yahoo.com - August 30 at 9:50 AM
finanznachrichten.de logoEnochian BioSciences, Inc.: Distinguished Scientific and Clinical Leader to Join Enochian BioSciences' Hepatitis B Cure Scientific Advisory Board
finanznachrichten.de - August 25 at 8:22 AM
finance.yahoo.com logoDistinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board
finance.yahoo.com - August 23 at 10:23 AM
finanznachrichten.de logoEnochian BioSciences, Inc.: Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
finanznachrichten.de - July 20 at 8:33 AM
finance.yahoo.com logoEnochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
finance.yahoo.com - July 20 at 8:33 AM
finance.yahoo.com logoEnochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program
finance.yahoo.com - July 12 at 3:09 PM
marketwatch.com logoEnochian Pre-IND Request for Potential Cure for Hepatitis B Virus Infection Accepted by FDA
marketwatch.com - July 12 at 9:38 AM
finanznachrichten.de logoEnochian BioSciences, Inc.: Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
finanznachrichten.de - July 12 at 9:38 AM
finance.yahoo.com logoEnochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
finance.yahoo.com - July 12 at 9:38 AM
finance.yahoo.com logoEnochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
finance.yahoo.com - June 30 at 9:06 AM
finance.yahoo.com logoWhy Enochian BioSciences Was a Winner on Monday
finance.yahoo.com - June 21 at 5:53 PM
markets.businessinsider.com logoWhy Enochian Biosciences, Raven Industries And GE Share Are Trading Higher Today
markets.businessinsider.com - June 21 at 12:14 PM
msn.com logoWhy Enochian Biosciences, Raven Industries And GE Shares Are Trading Higher Today
msn.com - June 21 at 12:14 PM
finance.yahoo.com logoEnochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology
finance.yahoo.com - June 21 at 12:14 PM
finance.yahoo.com logoEnochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
finance.yahoo.com - June 21 at 7:13 AM
finanznachrichten.de logoEnochian BioSciences, Inc.: Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finanznachrichten.de - June 16 at 1:16 PM
finance.yahoo.com logoPioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV
finance.yahoo.com - June 15 at 9:33 AM
marketwatch.com logoEnochian BioSciences Unveils $29M Registered Direct Offering
marketwatch.com - June 14 at 6:31 PM
finance.yahoo.com logoHere's Why Enochian BioSciences Stock Skyrocketed Today
finance.yahoo.com - June 14 at 6:31 PM
ca.finance.yahoo.com logoEnochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
ca.finance.yahoo.com - June 14 at 8:11 AM
finance.yahoo.com logoEnochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
finance.yahoo.com - June 14 at 8:11 AM
finance.yahoo.com logoIs Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - April 30 at 10:03 AM
baystreet.ca logoEnochian Darts Ahead on Positive Results
baystreet.ca - March 25 at 2:22 PM
finance.yahoo.com logoSeraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy
finance.yahoo.com - March 24 at 6:57 PM
finance.yahoo.com logoSeraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy
finance.yahoo.com - March 24 at 6:57 PM
marketwatch.com logo8-K: Enochian Biosciences Inc
marketwatch.com - March 11 at 7:00 AM
wsj.com logoDow Jones U.S. Total Stock Market Index
wsj.com - November 28 at 8:58 PM
finance.yahoo.com logoWhat You Need To Know About Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Investor Composition
finance.yahoo.com - November 1 at 1:54 PM
nasdaq.com logoEnochian Biosciences, Inc. Common Stock (ENOB)
nasdaq.com - October 30 at 11:03 PM
markets.businessinsider.com logoEnochian Biosciences Inc Registered Shs - Profile
markets.businessinsider.com - October 19 at 6:40 PM
www.reuters.com logoEnochian Biosciences Inc
www.reuters.com - July 30 at 5:42 PM
finance.yahoo.com logoDistinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board
finance.yahoo.com - July 27 at 8:14 AM
seekingalpha.com logoEnochian Biosciences -3.8% on filing to offer shares
seekingalpha.com - July 13 at 10:25 PM
feeds.benzinga.com logoHere's Why Small-Cap Biopharma Enochian Is Surging Higher
feeds.benzinga.com - June 8 at 1:20 PM
www.benzinga.com logoMid-Day Market Update: Crude Oil Down Over 3%; Enochian Biosciences Shares Spike Higher
www.benzinga.com - June 8 at 1:05 PM
247wallst.com logoEnochian Bio's HIV Treatment Is on Its Way With the FDA
247wallst.com - June 8 at 1:05 PM
Get Enochian Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.